or Try an Advanced Search...

    Factor Vii Stocks List

    Symbol Grade Name % Change
    KMDA D Kamada Ltd. -1.56
    GRFS D Grifols, S.A. 0.39
    BIIB D Biogen Idec Inc. 0.23
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Major
    Related Stock Lists: Medicine Biopharmaceutical Blood Plasma Hemophilia In Vitro Alpha 1 Antitrypsin Alzheimer's Disease Analytical Instruments Anesthesia Antibody Antitrypsin Deficiency Autoimmune Disorders Bank Products Biotechnology Blood Blood Bank Blood Donation Blood Products Bronchiectasis Cardiac Surgery

    Related ETFs - A few ETFs which own one or more of the above listed Factor Vii stocks.

    Symbol Grade Name Weight
    BIS F ProShares UltraShort Nasdaq Biotechnology 6.48
    PBE C PowerShares Dynamic Biotech & Genome 5.07
    IBRN D iShares Neuroscience and Healthcare ETF 4.68
    BBH B Market Vectors Biotech ETF 4.58
    MNTL C Tema Neuroscience and Mental Health ETF 4.26
    View all Factor Vii ETFs...
    Compare ETFs
    Compare BIS to BBH Compare BIS to MNTL Compare IBRN to MNTL

        Factor Vii Stocks Recent News

        Date Stock Title
        May 17 BIIB Ionis, Biogen Down on Ending Development of ALS Drug
        May 17 BIIB Ionis (IONS), Biogen Down on Ending Development of ALS Drug
        May 16 BIIB Biogen also drops collaboration with Ionis on Angelman syndrome candidate
        May 16 BIIB Biogen and Ionis drop ALS candidate after trial setback
        May 16 BIIB Biogen, Ionis shelve ALS drug following study failure
        May 16 BIIB REFILE-UPDATE 2-Biogen, Ionis to discontinue development of experimental ALS drug
        May 16 BIIB Biogen and Ionis Announce Topline Phase 1/2 Study Results of Investigational Drug in Amyotrophic Lateral Sclerosis
        May 16 BIIB Ionis and Biogen Announce Topline Phase 1/2 Study Results of Investigational Drug in Amyotrophic Lateral Sclerosis
        May 15 BIIB Eisai projects major growth for Alzheimer's therapy Leqembi
        May 15 BIIB Biogen (BIIB) Partner Begins Filing for Leqembi SC Autoinjector
        May 15 BIIB Biogen Stock Continues Its 20% Sprint On A Twist In Alzheimer's Treatment
        May 15 BIIB Eisai sets new revenue target for Alzheimer’s drug Leqembi
        May 15 BIIB Biogen partner Eisai begins FDA submissions for injectable Alzheimer’s therapy
        May 15 BIIB UPDATE 1-Eisai starts rolling submission for injectable version of Alzheimer's drug with US FDA
        May 14 BIIB Eisai Initiates Rolling Biologics License Application to US FDA for LEQEMBI® (lecanemab-irmb) for Subcutaneous Maintenance Dosing for the Treatment of Early Alzheimer’s Disease Under the Fast Track Status
        May 14 BIIB Eisai starts rolling submission for injectable version of Alzheimer's drug with US FDA
        May 13 BIIB 15 Most Depressed States in the US
        Related Industries: Biotechnology Drug Manufacturers - Major
        Related Stock Lists: Medicine Biopharmaceutical Blood Plasma Hemophilia In Vitro Alpha 1 Antitrypsin Alzheimer's Disease Analytical Instruments Anesthesia Antibody Antitrypsin Deficiency Autoimmune Disorders Bank Products Biotechnology Blood Blood Bank Blood Donation Blood Products Bronchiectasis Cardiac Surgery
        Factor Vii

        Browse All Tags